Skip to main content
GKB logo

GKB — Investor Relations & Filings

Ticker · 1707 ISIN · TW0001707008 TW Manufacturing
Filings indexed 2,129 across all filing types
Latest filing 2022-12-26 Investor Presentation
Country TW Taiwan
Listing TW 1707

Grape King Bio Ltd. is a biotechnology firm specializing in the research, development, and production of health supplements and functional beverages. Established in 1969, the company has evolved into a prominent provider of probiotics, energy drinks, and nutritional products tailored for diverse age groups. It operates a dedicated Biotech Research Institute staffed by over 160 specialists, focusing on proprietary fermentation technology and innovative formulations that have garnered over 170 international awards. The company offers a comprehensive one-stop OEM/ODM platform, providing integrated manufacturing services across various dosage forms. Guided by the philosophy of "Technology, Health, and Hope," Grape King Bio serves global markets through its own brands and strategic subsidiaries, emphasizing high-quality standards and advanced biotechnological applications to enhance consumer well-being.

Recent filings

Filing Released Lang Actions
111年12月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting (法人說明會), including date, time, location, and links to presentation materials. The content focuses on an investor presentation event rather than a full financial report or regulatory filing. The presence of presentation files and the context of a scheduled meeting indicate this is an Investor Presentation (IP). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is Investor Presentation (IP).
2022-12-26 Chinese
111年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and types of shares. The content is focused on insider share transactions and holdings disclosures. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is not a report or announcement of a report but a direct disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data on insider holdings and changes. Therefore, the correct classification is DIRS with high confidence.
2022-12-07 Chinese
111年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors and senior management, with specific numbers of shares held, pledged shares, and related percentages. It lists individual insiders by name and position, showing their shareholdings and any pledges. The document is titled with the company name and appears to be a disclosure of insider shareholdings. There is no indication of financial results, earnings, or management discussion. The content is focused on insider share transactions or holdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions or holdings by company directors and executives. The document length is 2676 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is DIRS with high confidence.
2022-12-07 Chinese
111年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (葡萄王) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, but rather a summary of specific financial data points related to guarantees and loans. The document length is very short (602 characters), and it does not present a full report but rather a regulatory disclosure of financial information. This type of document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-12-06 Chinese
111年11月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 葡萄王 (Grape King) for the month of November in the 111th year of the Republic of China calendar (equivalent to 2022). It includes comparative figures from the previous year and percentage changes. The document is very short (777 characters) and contains no detailed financial statements, management discussion, or comprehensive analysis. It appears to be a regulatory disclosure of revenue figures rather than a full financial report or earnings release. There is no indication of an earnings announcement or conference call transcript, nor is it a notice of dividend, capital change, or management change. It is a brief financial data disclosure likely filed for regulatory compliance. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2022-12-06 Chinese
本公司受邀參加安擘諮詢主辦之線上法人座談會
Regulatory Filings Classification · 90% confidence The document is a short announcement (625 characters) about the company 1707 葡萄王 participating in an online investor conference hosted by 安擘諮詢. It specifies the date, time, and nature of the event (online investor meeting). There is no detailed financial data, no full transcript, no financial statements, or report attached. The document serves as a notification of an upcoming or held investor presentation event rather than the presentation itself or a financial report. According to the definitions, this fits best as an Investor Presentation (IP) announcement. However, since the document is very brief and only announces participation in an investor meeting without providing the presentation materials, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about the event, not the presentation content itself.
2022-11-29 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.